Skip to main content
. 2023 Feb 7;2023:6483785. doi: 10.1155/2023/6483785

Table 4.

Adverse reactions in the ipratropium bromide group and combined intervention group.

Group Cases (n) Spontaneous pneumothorax Chronic respiratory failure Chronic pulmonary heart disease Sleep apnea Total incidence
Control 20 2 2 1 1 6f
Ipratropium bromide 24 1 2 1 0 4
Combined intervention 24 1 1 1 0 3a

BT, before treatment; AT, after treatment; compared with the control group, aP < 0.05, compared with the ipratropium bromide group, fP < 0.01.